These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 17624591)
1. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York. Gaudet MM; Gammon MD; Bensen JT; Sagiv SK; Shantakumar S; Teitelbaum SL; Eng SM; Neugut AI; Santella RM Breast Cancer Res Treat; 2008 Mar; 108(1):93-9. PubMed ID: 17624591 [TBL] [Abstract][Full Text] [Related]
2. Polymorphism in the DNA repair gene XPD, polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, and breast cancer risk. Terry MB; Gammon MD; Zhang FF; Eng SM; Sagiv SK; Paykin AB; Wang Q; Hayes S; Teitelbaum SL; Neugut AI; Santella RM Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2053-8. PubMed ID: 15598760 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in XRCC1 modify the association between polycyclic aromatic hydrocarbon-DNA adducts, cigarette smoking, dietary antioxidants, and breast cancer risk. Shen J; Gammon MD; Terry MB; Wang L; Wang Q; Zhang F; Teitelbaum SL; Eng SM; Sagiv SK; Gaudet MM; Neugut AI; Santella RM Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):336-42. PubMed ID: 15734955 [TBL] [Abstract][Full Text] [Related]
4. IGHMBP2 Thr671Ala polymorphism might be a modifier for the effects of cigarette smoking and PAH-DNA adducts to breast cancer risk. Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM Breast Cancer Res Treat; 2006 Sep; 99(1):1-7. PubMed ID: 16752224 [TBL] [Abstract][Full Text] [Related]
5. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue. Rundle A; Tang D; Zhou J; Cho S; Perera F Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1079-85. PubMed ID: 11045791 [TBL] [Abstract][Full Text] [Related]
6. Environmental toxins and breast cancer on Long Island. I. Polycyclic aromatic hydrocarbon DNA adducts. Gammon MD; Santella RM; Neugut AI; Eng SM; Teitelbaum SL; Paykin A; Levin B; Terry MB; Young TL; Wang LW; Wang Q; Britton JA; Wolff MS; Stellman SD; Hatch M; Kabat GC; Senie R; Garbowski G; Maffeo C; Montalvan P; Berkowitz G; Kemeny M; Citron M; Schnabel F; Schuss A; Hajdu S; Vinceguerra V Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):677-85. PubMed ID: 12163319 [TBL] [Abstract][Full Text] [Related]
7. Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer. Shen J; Liao Y; Hopper JL; Goldberg M; Santella RM; Terry MB Br J Cancer; 2017 Apr; 116(9):1229-1233. PubMed ID: 28350789 [TBL] [Abstract][Full Text] [Related]
8. The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Rundle A; Tang D; Hibshoosh H; Estabrook A; Schnabel F; Cao W; Grumet S; Perera FP Carcinogenesis; 2000 Jul; 21(7):1281-9. PubMed ID: 10874004 [TBL] [Abstract][Full Text] [Related]
9. Residential environmental exposures and other characteristics associated with detectable PAH-DNA adducts in peripheral mononuclear cells in a population-based sample of adult females. Shantakumar S; Gammon MD; Eng SM; Sagiv SK; Gaudet MM; Teitelbaum SL; Britton JA; Terry MB; Paykin A; Young TL; Wang LW; Wang Q; Stellman SD; Beyea J; Hatch M; Camann D; Prokopczyk B; Kabat GC; Levin B; Neugut AI; Santella RM J Expo Anal Environ Epidemiol; 2005 Nov; 15(6):482-90. PubMed ID: 15856074 [TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in DNA repair genes, traffic-related polycyclic aromatic hydrocarbon exposure and breast cancer incidence. Mordukhovich I; Beyea J; Herring AH; Hatch M; Stellman SD; Teitelbaum SL; Richardson DB; Millikan RC; Engel LS; Shantakumar S; Steck SE; Neugut AI; Rossner P; Santella RM; Gammon MD Int J Cancer; 2016 Jul; 139(2):310-21. PubMed ID: 26946191 [TBL] [Abstract][Full Text] [Related]
12. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women. Lajin B; Alhaj Sakur A; Alachkar A Breast Cancer Res Treat; 2013 Apr; 138(2):611-9. PubMed ID: 23468244 [TBL] [Abstract][Full Text] [Related]
13. Associations between polycyclic aromatic hydrocarbon-related exposures and p53 mutations in breast tumors. Mordukhovich I; Rossner P; Terry MB; Santella R; Zhang YJ; Hibshoosh H; Memeo L; Mansukhani M; Long CM; Garbowski G; Agrawal M; Gaudet MM; Steck SE; Sagiv SK; Eng SM; Teitelbaum SL; Neugut AI; Conway-Dorsey K; Gammon MD Environ Health Perspect; 2010 Apr; 118(4):511-8. PubMed ID: 20064791 [TBL] [Abstract][Full Text] [Related]
14. Xeroderma pigmentosum complementation group C genotypes/diplotypes play no independent or interaction role with polycyclic aromatic hydrocarbons-DNA adducts for breast cancer risk. Shen J; Gammon MD; Terry MB; Teitelbaum SL; Eng SM; Neugut AI; Santella RM Eur J Cancer; 2008 Mar; 44(5):710-7. PubMed ID: 18053706 [TBL] [Abstract][Full Text] [Related]
15. Polycyclic aromatic hydrocarbon (PAH)-DNA adducts and breast cancer: modification by gene promoter methylation in a population-based study. White AJ; Chen J; McCullough LE; Xu X; Cho YH; Teitelbaum SL; Neugut AI; Terry MB; Hibshoosh H; Santella RM; Gammon MD Cancer Causes Control; 2015 Dec; 26(12):1791-802. PubMed ID: 26407953 [TBL] [Abstract][Full Text] [Related]
16. Smoky coal exposure, NBS1 polymorphisms, p53 protein accumulation, and lung cancer risk in Xuan Wei, China. Lan Q; Shen M; Berndt SI; Bonner MR; He X; Yeager M; Welch R; Keohavong P; Donahue M; Hainaut P; Chanock S Lung Cancer; 2005 Sep; 49(3):317-23. PubMed ID: 15921821 [TBL] [Abstract][Full Text] [Related]
17. Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902 [TBL] [Abstract][Full Text] [Related]
18. Coordination of TP53 abnormalities in breast cancer: data from analysis of TP53 polymorphisms, loss of heterozygosity, methylation, and mutations. Denisov EV; Sukhanovskaya TV; Dultseva TS; Malinovskaya EA; Litviakov NV; Slonimskaya EM; Choinzonov EL; Cherdyntseva NV Genet Test Mol Biomarkers; 2011 Dec; 15(12):901-7. PubMed ID: 21810023 [TBL] [Abstract][Full Text] [Related]
19. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466 [TBL] [Abstract][Full Text] [Related]
20. The interaction between alcohol consumption and GSTM1 genotype on polycyclic aromatic hydrocarbon-DNA adduct levels in breast tissue. Rundle A; Tang D; Mooney L; Grumet S; Perera F Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):911-4. PubMed ID: 14504203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]